Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,442,678 | 4,806,824 | 5,622,408 | 4,945,473 | 4,151,515 |
| Marketable Securities | 157,704 | 293,832 | 146,102 | 166,127 | 339,457 |
| Receivables | 11,192,960 | 10,280,110 | 9,447,510 | 9,360,618 | 10,231,820 |
| Inventories | 8,246,452 | 8,109,763 | 7,557,000 | 7,244,415 | 7,696,951 |
| Other current assets | 9,436 | 113,531 | 5,040 | 3,837 | 78,037 |
| TOTAL | $24,049,230 | $23,604,060 | $22,778,060 | $21,720,470 | $22,497,780 |
| Non-Current Assets | |||||
| PPE Net | 12,592,080 | 12,178,000 | 11,529,460 | 11,791,180 | 11,555,830 |
| Investments And Advances | 1,459,776 | 1,304,881 | 1,299,804 | 1,529,646 | 1,441,065 |
| Intangibles | 32,325,334 | 29,530,121 | 29,200,247 | 28,748,918 | 28,210,018 |
| Other Non-Current Assets | 12,252,420 | 12,527,928 | 11,650,379 | 12,197,556 | 11,793,837 |
| TOTAL | $58,629,610 | $55,540,930 | $53,679,890 | $54,267,300 | $53,000,750 |
| Total Assets | $82,678,840 | $79,144,980 | $76,457,950 | $75,987,770 | $75,498,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,849,602 | 2,737,980 | 2,466,101 | 3,001,787 | 3,661,189 |
| Accounts payable and accrued liabilities | 21,128,330 | 19,793,590 | 19,080,170 | 19,596,600 | 18,696,130 |
| Accrued Expenses | 436,720 | 775,984 | 790,966 | 898,364 | 738,741 |
| Other current liabilities | 3,341,444 | 3,909,301 | 3,899,412 | 4,229,849 | 4,813,521 |
| TOTAL | $28,756,100 | $27,216,860 | $26,236,640 | $27,726,600 | $27,909,580 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,075,620 | 20,440,020 | 20,749,000 | 18,704,620 | 17,225,150 |
| Other Non-Current Liabilities | 11,912,744 | 11,532,913 | 11,579,846 | 12,234,994 | 12,324,480 |
| TOTAL | $32,690,620 | $32,756,930 | $33,024,090 | $31,538,570 | $30,091,980 |
| Total Liabilities | $61,446,720 | $59,973,780 | $59,260,730 | $59,265,170 | $58,001,560 |
| Shareholders' Equity | |||||
| Common Shares | 1,818,317 | 1,801,724 | 1,699,066 | 1,722,609 | 1,753,209 |
| Retained earnings | 13,500,570 | 11,749,270 | 10,462,670 | 9,962,509 | 10,648,010 |
| Other shareholders' equity | 1,214,454 | 964,305 | 647,376 | 599,336 | 578,767 |
| TOTAL | $21,232,120 | $19,171,200 | $17,197,210 | $16,722,600 | $17,496,970 |
| Total Liabilities And Equity | $82,678,840 | $79,144,980 | $76,457,940 | $75,987,770 | $75,498,530 |